Results 181 to 190 of about 1,849,608 (371)

Ricin Antibodies' Neutralizing Capacity against Different Ricin Isoforms and Cultivars. [PDF]

open access: yesToxins (Basel), 2021
Orsini Delgado ML   +13 more
europepmc   +1 more source

Carbon‐Based Flexible Electrode for Efficient Electrochemical Generation of Reactive Chlorine Species in Tumor Therapy

open access: yesAdvanced Healthcare Materials, EarlyView.
A flexible electrode loaded with a carbon nanowire network (CC@C‐NWN) is developed for electrochemically generating reactive chlorine species (RCS) from abundant chloride ions in body fluids for tumor therapy. CC@C‐NWN enhances chlorine evolution, inducing redox dysregulation and synergistic apoptosis‐ferroptosis in tumor cells.
Cuinan Jiang   +10 more
wiley   +1 more source

Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.

open access: yesAnnual Review of Immunology, 2016
HIV employs multiple means to evade the humoral immune response, particularly the elicitation of and recognition by broadly neutralizing antibodies (bnAbs).
D. Burton, L. Hangartner
semanticscholar   +1 more source

Tackling influenza with broadly neutralizing antibodies

open access: yesCurrent Opinion in Virology, 2017
Monoclonal antibodies have revolutionized the treatment of several human diseases, including cancer, autoimmunity and inflammatory conditions and represent a new frontier for the treatment of infectious diseases. In the last decade, new methods have allowed the efficient interrogation of the human antibody repertoire from influenza immune individuals ...
Nicole L. Kallewaard   +5 more
openaire   +2 more sources

Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting

open access: yesAdvanced Materials, EarlyView.
CART cell therapy has proven effective for blood cancers but struggles with solid tumors due to diverse antigens and complex environments. Recent efforts focus on improving CAR design and validation platforms. Advances in protein engineering, machine learning, and organoid systems aim to enhance CAR‐T therapy against solid tumors.
Danqing Zhu   +4 more
wiley   +1 more source

Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern. [PDF]

open access: yesCell Discov, 2021
Gorchakov AA   +22 more
europepmc   +1 more source

Age-specific kinetics of neutralizing antibodies and infection enhancement among ≤1 year-old Indian infants. [PDF]

open access: yesFront Cell Infect Microbiol
BackgroundInfants born to dengue-immune mothers acquire maternal antibodies to dengue. Maternal antibodies decline over time, making infants susceptible to primary dengue infections. Another important concern is the role of maternal antibodies in causing
Chelluboina S   +3 more
europepmc   +2 more sources

State‐of‐the‐Art, Insights, and Perspectives for MOFs‐Nanocomposites and MOF‐Derived (Nano)Materials

open access: yesAdvanced Materials, EarlyView.
Different approaches to MOF‐NP composite formation, such as ship‐in‐a‐bottle, bottle‐around‐the‐ship and in situ one‐step synthesis, are used. Owing to synergistic effects, the advantageous features of the components of the composites are beneficially combined, and their individual drawbacks are mitigated.
Stefanos Mourdikoudis   +6 more
wiley   +1 more source

Human neutralizing antibodies elicited by SARS-CoV-2 infection

open access: yesNature, 2020
B. Ju   +23 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy